Literature DB >> 9382886

C-myc-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent.

M Trudel1, J Lanoix, L Barisoni, M J Blouin, M Desforges, C L'Italien, V D'Agati.   

Abstract

The SBM mouse is a unique transgenic model of polycystic kidney disease (PKD) induced by the dysregulated expression of c-myc in renal tissue. In situ hybridization analysis demonstrated intense signal for the c-myc transgene overlying tubular cystic epithelium in SBM mice. Renal proliferation index in SBM kidneys was 10-fold increased over nontransgenic controls correlating with the presence of epithelial hyperplasia. The specificity of c-myc for the proliferative potential of epithelial cells was demonstrated by substitution of c-myc with the proto-oncogene c-fos or the transforming growth factor (TGF)-alpha within the same construct. No renal abnormalities were detected in 13 transgenic lines established, indicating that the PKD phenotype is dependent on functions specific to c-myc. We also investigated another well characterized function of c-myc, the regulation of apoptosis through pathways involving p53 and members of the bcl-2 family, which induce and inhibit apoptosis, respectively. The SBM kidney tissues, which overexpress c-myc, displayed a markedly elevated (10-100-fold) apoptotic index. However, no significant difference in bcl-2, bax, or p53 expression was observed in SBM kidney compared with controls. Direct proof that the heightened renal cellular apoptosis in PKD is not occurring through p53 was obtained by successive matings between SBM and p53(-/-) mice. All SBM offspring, irrespective of their p53 genotype, developed PKD with increased renal epithelial apoptotic index. In addition, overexpression of both bcl-2 and c-myc in double transgenic mice (SBB+/SBM+) also produced a similar PKD phenotype with a high apoptotic rate, showing that c-myc can bypass bcl-2 in vivo. Thus, the in vivo c-myc apoptotic pathway in SBM mice occurs through a p53- and bcl-2-independent mechanism. We conclude that the pathogenesis of PKD is c-myc specific and involves a critical imbalance between the opposing processes of cell proliferation and apoptosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9382886      PMCID: PMC2199149          DOI: 10.1084/jem.186.11.1873

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  42 in total

Review 1.  Quantitation of RNA using the polymerase chain reaction.

Authors:  K P Foley; M W Leonard; J D Engel
Journal:  Trends Genet       Date:  1993-11       Impact factor: 11.639

2.  c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms.

Authors:  D Sakamuro; V Eviner; K J Elliott; L Showe; E White; G C Prendergast
Journal:  Oncogene       Date:  1995-12-07       Impact factor: 9.867

3.  Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death.

Authors:  Z N Oltvai; C L Milliman; S J Korsmeyer
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

4.  Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease (ADPKD).

Authors:  J Lanoix; V D'Agati; M Szabolcs; M Trudel
Journal:  Oncogene       Date:  1996-09-19       Impact factor: 9.867

5.  A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice.

Authors:  A C Davis; M Wims; G D Spotts; S R Hann; A Bradley
Journal:  Genes Dev       Date:  1993-04       Impact factor: 11.361

6.  Apoptosis and remodeling of mammary gland tissue during involution proceeds through p53-independent pathways.

Authors:  M Li; J Hu; K Heermeier; L Hennighausen; P A Furth
Journal:  Cell Growth Differ       Date:  1996-01

7.  Bax-deficient mice with lymphoid hyperplasia and male germ cell death.

Authors:  C M Knudson; K S Tung; W G Tourtellotte; G A Brown; S J Korsmeyer
Journal:  Science       Date:  1995-10-06       Impact factor: 47.728

8.  Apoptosis and loss of renal tissue in polycystic kidney diseases.

Authors:  D Woo
Journal:  N Engl J Med       Date:  1995-07-06       Impact factor: 91.245

9.  Analysis of the role of membrane polarity in polycystic kidney disease of transgenic SBM mice.

Authors:  L Barisoni; M Trudel; N Chrétien; L Ward; J van Adelsberg; V D'Agati
Journal:  Am J Pathol       Date:  1995-12       Impact factor: 4.307

Review 10.  Bcl-2 and the regulation of programmed cell death.

Authors:  J C Reed
Journal:  J Cell Biol       Date:  1994-01       Impact factor: 10.539

View more
  19 in total

Review 1.  c-Myc induction of programmed cell death may contribute to carcinogenesis: a perspective inspired by several concepts of chemical carcinogenesis.

Authors:  Chenguang Wang; Yanhong Tai; Michael P Lisanti; D Joshua Liao
Journal:  Cancer Biol Ther       Date:  2011-04-01       Impact factor: 4.742

2.  c-Myc is necessary for DNA damage-induced apoptosis in the G(2) phase of the cell cycle.

Authors:  S Adachi; A J Obaya; Z Han; N Ramos-Desimone; J H Wyche; J M Sedivy
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

Review 3.  MYC and the control of apoptosis.

Authors:  Steven B McMahon
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-01       Impact factor: 6.915

Review 4.  Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease.

Authors:  Peter C Harris; Vicente E Torres
Journal:  J Clin Invest       Date:  2014-06-02       Impact factor: 14.808

5.  Cellular activation triggered by the autosomal dominant polycystic kidney disease gene product PKD2.

Authors:  T Arnould; L Sellin; T Benzing; L Tsiokas; H T Cohen; E Kim; G Walz
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

6.  Ionizing radiation induces caspase-dependent but Chk2- and p53-independent cell death in Drosophila melanogaster.

Authors:  Anita Wichmann; Burnley Jaklevic; Tin Tin Su
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-19       Impact factor: 11.205

7.  Caspase inhibition reduces tubular apoptosis and proliferation and slows disease progression in polycystic kidney disease.

Authors:  Yunxia Tao; Jun Kim; Sarah Faubel; Joe C Wu; Sandor A Falk; Robert W Schrier; Charles L Edelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-29       Impact factor: 11.205

8.  Pkd1 transgenic mice: adult model of polycystic kidney disease with extrarenal and renal phenotypes.

Authors:  Almira Kurbegovic; Olivier Côté; Martin Couillard; Christopher J Ward; Peter C Harris; Marie Trudel
Journal:  Hum Mol Genet       Date:  2010-01-06       Impact factor: 6.150

9.  Rapamycin and dexamethasone during pregnancy prevent tuberous sclerosis complex-associated cystic kidney disease.

Authors:  Morris Nechama; Yaniv Makayes; Elad Resnick; Karen Meir; Oded Volovelsky
Journal:  JCI Insight       Date:  2020-07-09

10.  Apoptosis and autophagy in polycystic kidney disease (PKD).

Authors:  Kristen L Nowak; Charles L Edelstein
Journal:  Cell Signal       Date:  2019-12-24       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.